Drug Detail

Information about Plocabulin

Generic Name
Plocabulin
IND
PM060184
Brand Name (US)
Manufacturer
PharmaMar
Drug Type
Delivery
Intraveneous
Approval Status
Phase 1
Indications
Overall Strategy
Modulate microtubule dynamics
Strategy
Tubulin binding agent
Drug Category
Tubulin inhibitor

PM184
This compound inhibits tubulin polymerization. These proteins form part of the cell’s skeleton (the cytoskeleton). As a result, the cytoskeleton becomes degraded and the tumor cells lose the capacity to mobilize and divide.


Links

 

PharMar Mechanism of Action page
   

 

PharmaMar publication on PM184
   

Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed